A Systematic Review of Clinical Practice Guidelines for Managing Pulmonary Toxicities Caused by Immune Checkpoint Inhibitors: Quality of Treatment Recommendations and Differences in Management Strategies Between Guidelines.

导出 LinkOut

翻译打印收藏纠错

作者： Kofi N,Donkor ^[1] ; Hyeree,Jang ^[1] ; Reena,Sail ^[2]

作者单位： Department of Hematology/Oncology, Loma Linda University Health, Loma Linda, CA, USA. ^[1] Department of Hematology/Oncology, Scripps MD Anderson Cancer Center, San Diego, CA, USA. ^[2]

关键词 AGREE II AGREE-REX clinical practice guideline immune-checkpoint inhibitor immune-related adverse event immunotherapy-related toxicity lung toxicity pneumonitis pulmonary toxicity systematic review

DOI 10.1177/11795549231203153

PMID 38033741

发布时间 2023-12-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical Medicine Insights. Oncology

2023年17卷

11795549231203153页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A Systematic Review of Clinical Practice Guidelines for Managing Pulmonary Toxicities Caused by Immune Checkpoint Inhibitors: Quality of Treatment Recommendations and Differences in Management Strategies Between Guidelines.

Clinical Medicine Insights. Oncology

相似文献

Clinical Medicine Insights. Oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A Systematic Review of Clinical Practice Guidelines for Managing Pulmonary Toxicities Caused by Immune Checkpoint Inhibitors: Quality of Treatment Recommendations and Differences in Management Strategies Between Guidelines.

Clinical Medicine Insights. Oncology

相似文献

Clinical Medicine Insights. Oncology

相关期刊

检索历史清除